Shock Wave Therapy Market Report 2025

The shock wave therapy market size has grown rapidly in recent years. It will grow from $1.8 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth during the historic period is linked to the increasing use of extracorporeal shock wave therapy, rising popularity of outpatient rehabilitation centers, expanding insurance coverage for physiotherapy, growing demand for post-surgical pain management, and higher public spending on sports injury rehabilitation.

The shock wave therapy market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth projected for the forecast period is driven by the rise of wearable diagnostic and monitoring devices, increasing partnerships between sports teams and medical technology firms, growing demand for aesthetic treatments using shock waves, expanding adoption of ESWT in veterinary orthopedics, and an increase in clinical trials exploring new applications of shock wave therapy. Primary trends during the forecast period include the development of portable and wearable shock wave devices, emergence of multi-modality therapeutic platforms, use of blockchain for patient data security in physiotherapy devices, sustainable medical device manufacturing, and voice-enabled therapy devices for hands-free control.

The increasing occurrence of musculoskeletal diseases is anticipated to drive growth in the shock wave therapy market. These diseases include conditions that impact bones, muscles, joints, tendons, ligaments, and other supportive body structures. The rising number of musculoskeletal diseases is linked to aging populations, as the natural deterioration of bones and joints heightens the risk of degenerative disorders. Shock wave therapy assists in treating these conditions by promoting healing, alleviating pain, and enhancing mobility through targeted non-invasive energy pulses. For example, in January 2024, the Office for Health Improvement and Disparities, a UK government department, reported that in 2023, 18.4% of people aged 16 and older self-reported long-term musculoskeletal conditions, slightly up from 17.6% in 2022. The prevalence among males was 15.8% compared to 20.9% in females. This growing prevalence is contributing to the expansion of the shock wave therapy market.

Leading companies in the shock wave therapy market are developing advanced products such as high-resolution touchscreens to offer intuitive controls, simplify treatment settings, improve the experience for professionals and home users, and allow precise adjustment of treatment parameters for more effective and personalized pain relief. High-resolution touchscreens provide sharp visuals and responsive touch controls, enabling users to easily navigate device settings and adjust parameters accurately during shock wave therapy. For instance, in March 2024, Chengqiao Technology Inc. (SHEYERA), based in China, released the DR-88 Shockwave Therapy Device, featuring a high-resolution touchscreen that allows selection of energy levels, treatment durations, and preset modes for targeted therapy. The device also offers multiple interchangeable applicator heads and adjustable intensity settings to support both focused and wide-area treatments for conditions such as chronic pain, muscle fatigue, tendonitis, plantar fasciitis, and post-exercise recovery. Incorporating advanced touchscreen technology, the DR-88 delivers a more customized, efficient, and user-friendly approach to pain management, making it suitable for professional therapy centers, sports rehabilitation clinics, and home users seeking convenient, non-invasive options for improving mobility and musculoskeletal health.

In September 2022, Advanced MedTech Holdings Pte. Ltd., a medical technology company from Singapore, acquired a majority stake in Shenzhen Wikkon Precision Instruments Co. Ltd. (WIKKON) for an undisclosed amount. This acquisition aims to enhance Advanced MedTech’s position in China’s urology market, broaden its product range, and utilize WIKKON’s strong research and development, manufacturing, and distribution capabilities. It also establishes a solid foundation to address growing domestic demand, support China’s local medical device initiatives, and serve healthcare requirements in emerging markets with innovative and cost-effective urology products. WIKKON specializes in shock wave therapy and related urology solutions.

Major players in the shock wave therapy market are Siemens Healthineers AG, Boston Scientific Corporation, BTL Industries Limited, Shockwave Medical Inc., Richard Wolf GmbH, Dornier MedTech GmbH, EDAP TMS S.A., Enraf-Nonius B.V., Storz Medical AG, Medispec Ltd., EMS Electro Medical Systems S.A., Zimmer MedizinSysteme GmbH, GymnaUniphy, Elvation Medical, HANIL-TM, MTS Medical UG, Venn Healthcare, CuraMedix Inc., Kinas Medical Inc., TensCare Ltd.

North America was the largest region in the shock wave therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in shock wave therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the shock wave therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Shock wave therapy is a non-invasive treatment that uses high-energy acoustic waves to stimulate healing in injured or inflamed tissues. It enhances blood circulation, accelerates tissue regeneration, and aids in breaking down calcifications. This therapy is commonly applied to musculoskeletal conditions, chronic pain, and certain tendon disorders.

The primary types of shock wave therapy include radial shock wave therapy and focused shock wave therapy. Radial shock wave therapy is a non-invasive method that uses low-energy, radially dispersed pressure waves to treat superficial soft tissue conditions, such as tendon pain or muscle tightness. Primary techniques include electrohydraulic, piezoelectric, radial, and electromagnetic shock waves. Applications cover orthopedics and sports injuries, cardiology, urology, dermatology and aesthetics, veterinary medicine, and neurology and pain management. End users include hospitals, specialty and sports medicine clinics, ambulatory surgical centers, physiotherapy and rehabilitation centers, and home-care settings.

The shock wave therapy market research report is one of a series of new reports that provides shock wave therapy market statistics, including shock wave therapy industry global market size, regional shares, competitors with the shock wave therapy market share, shock wave therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the shock wave therapy industry. This shock wave therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The shock wave therapy market consists of revenues earned by entities by providing services such as pain management, musculoskeletal disorder treatment, sports injury rehabilitation, and erectile dysfunction therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The shock wave therapy market also includes sales of ultrasound gels, shockwave therapy applicator heads, treatment cushions, disposable probe covers, conductive pads, patient positioning accessories, vibration or massage attachments, and cooling devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.